- The Advancing Rheumatology Patient Care MVP will be available for reporting through the RISE registry.
- MVP participation remains voluntary. Clinicians may choose their preferred reporting pathway.
- A multi-specialty group can participate in an MVP in the first three years of the pathway. By 2026 reporting, each specialty within the group will need to form a subgroup and report on specialty-specific measures.
- MVP and subgroup registration will be open between April 1 and Nov. 30, annually.
- Note: Subgroups will be assigned a unique identifier different from both TIN and NPI by the CMS upon completion of registration.
What Does This Mean for Your Practice?
Practices are encouraged to contact RISE staff at [email protected] with any questions regarding how they will be affected by these proposed policies. Effects on practices will vary depending on the practice’s eligibility and reporting factors, such as special status and hardship exceptions.
The ACR will comment on the proposed rule on behalf of the specialty. Members may submit their comments to the ACR Advocacy team or comment to the CMS directly. The proposed changes are not finalized until the CMS announces the final rule, expected around November 2022. At that time, the ACR will review and evaluate the final rule and provide more information.
Additional Resources
These are key takeaways from the proposed rule; this is not a comprehensive list of all proposed changes. Additional information is available from the QPP.
Questions?
Contact the Quality Payment Program at (866) 288-8292 or [email protected].
The ACR RISE registry staff are also available to assist you with questions related to reporting for MIPS. Contact the RISE team at (404) 633-3777 or [email protected].
